1. How to submit my research paper? What’s the process of publication of my paper?
The journal receives submitted manuscripts via email only. Please submit your research paper in .doc or.pdf format to the submission email: ijpmbs@ejournal.net.
You’ll be given a paper number if your submission is successful. Your paper then will undergo peer review process, which may take approximately one and a half months under normal circumstances, three tops.
After blind peer review, you will receive the notification letter with the review result of your paper...
2. Can I submit an abstract?
The journal publishes full research papers.[Read More]
IJPMBS 2023 Vol.12(3): 33-39
doi: 10.18178/ijpmbs.12.3.33-39

COVID-19, AIDS, Cancer Formation Mechanism and Treatment Plan

Jianghua Zhou
Box 2-3-2403, Haibitai, Qinhuangdao City, Hebei Province, 066000, China
Email: 1092375690@qq.com

Manuscript received February 22, 2023; revised March 15, 2023; accepted April 17, 2023.

Abstract—According to the new findings of the experiment, the author proposed the “New Theoretical System of Physics in the 21st Century”. This article continues to carry forward this innovative spirit, and proposes new strategic ideas for researching and disclosing the “formation mechanism” and “treatment plan” of COVID-19, AIDS, and cancer. Through the research on the “formation mechanism” of COVID-19, AIDS, and cancer, the method of injecting COVID-19 virus and HIV into animals is proposed to obtain the active biological antibodies of these viruses from animal blood; After extraction and then the active biological antibodies that can kill the virus are injected into patients’ bodies to kill COVID-19 virus and AIDS virus; In order to achieve the goal of treating COVID-19 and AIDS, once we find the active biological antibody to kill COVID-19 virus and AIDS virus according to this concept, we will be able to solve the thorny problem of the current epidemic situation. The author has applied for two invention patents for this concept: 1. Patent name: Active Biological Antibodies to Kill COVID-19 Virus and Use Methods, patent number: 2023100796195; 2. Patent name: Active biological antibody to kill AIDS virus and its use method, patent number: 2023100796119. The author hopes to cooperate with enterprises in the field of biopharmaceuticals to carry out research in this direction as soon as possible and make contributions to overcoming the medical problems of COVID-19 and AIDS as soon as possible.
Keywords—COVID-19, AIDS, cancers, formation mechanism, treatment plan

Cite: Jianghua Zhou, "COVID-19, AIDS, Cancer Formation Mechanism and Treatment Plan," International Journal of Pharma Medicine and Biological Sciences, Vol. 12, No. 3, pp. 32-39, July 2023. 

Copyright © 2023 by the authors. This is an open access article distributed under the Creative Commons Attribution License (CC BY-NC-ND 4.0), which permits use, distribution and reproduction in any medium, provided that the article is properly cited, the use is non-commercial and no modifications or adaptations are made.
Copyright © 2012-2024 International Journal of Pharma Medicine and Biological Sciences, All Rights Reserved
E-mail: ijpmbs@ejournal.net